ArticlePloS one2025
Long-term trends and future projections of the burden of tuberculosis among children and adolescents in China.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Tuberculosis infection and related factors among 15-17 years old teenagers in Eastern China.BMC public health · 2026Article
- Long-Term Trends and Determinants of Tuberculosis Burden in China, 1990-2023: Insights from the Global Burden of Disease Study 2023.Pathogens (Basel, Switzerland) · 2026Article
- Development and internal validation of a frailty risk stratification model for older patients with spinal tuberculosis.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChina ranks third in estimated TB incidence in 2023, accounting for 6.8% of the global cases. TB in children and adolescents is a public health issue that today warrants priority attention in China.
objectiveThe purpose of this study was to investigate the burden of TB among Chinese children and adolescents aged 0-19 years from 1990 to 2021 and to estimate the incidence rate, mortality rate, and disability-adjusted life years (DALYs) rate from 2022 to 2031.
methodsThe Joinpoint regression analysis was used to identify periods of significant change and autoregressive Integrated Moving Average (ARIMA) modeling was employed to predict the TB burden for 2022-2031.
resultsThe study indicated that China has significantly reduced the TB burden among children and adolescents over the past 32 years, the most pronounced reductions in incidence occurred during the periods 2010-2015 (APC = -8.64%, P < 0.05) and 2019-2021 (APC = -6.09%, P < 0.05). Meanwhile, death and DALYs rates showed a consistently rapid decline across the entire 32-year span. Adolescents aged 15-19 years have the highest incidence rates, and children under 5 continue to face high mortality and DALYs rates. Additionally, females experienced a more significant decline compared to males across all age groups. Despite minor fluctuations in some age groups, a downward trend in incidence, death, and DALYs rates was anticipated to continue until 2031, with persistent gender differences in future projections.
conclusionsOur findings demonstrate a persistent downward trajectory in TB burden among Chinese children and adolescents from 1990 to 2021, with significant gender disparities favoring females across all age groups. Notably, children younger than 5 years and adolescents aged 15-19 years are at higher risk, which emphasizes the importance of tailored interventions to ensure continued progress towards comprehensive TB control goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.